Comparative effectiveness of lipid-lowering treatments to reduce cardiovascular disease.

about

Comparative effectiveness of lipid-lowering treatments to reduce cardiovascular disease.

Item

http://www.wikidata.org/entity/Q47392228

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Comparative effectiveness of lipid-lowering treatments to reduce cardiovascular disease.

@en

Comparative effectiveness of lipid-lowering treatments to reduce cardiovascular disease.

@nl

type

Item

label

Comparative effectiveness of lipid-lowering treatments to reduce cardiovascular disease.

@en

Comparative effectiveness of lipid-lowering treatments to reduce cardiovascular disease.

@nl

prefLabel

Comparative effectiveness of lipid-lowering treatments to reduce cardiovascular disease.

@en

Comparative effectiveness of lipid-lowering treatments to reduce cardiovascular disease.

@nl

P1476

Comparative effectiveness of lipid-lowering treatments to reduce cardiovascular disease.

@en

P2093

Dong-Churl Suh

http://www.w3.org/2001/XMLSchema#string

Emmett R Henderson

http://www.w3.org/2001/XMLSchema#string

Scott K Griggs

http://www.w3.org/2001/XMLSchema#string

Seung-Mi Lee

http://www.w3.org/2001/XMLSchema#string

Taehwan Park

http://www.w3.org/2001/XMLSchema#string

P2860

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association

P304

51-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737167.2018.1407246

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29148854

http://www.w3.org/2001/XMLSchema#string